Xaira Therapeutics

Scientist in a lab wearing safety goggles while putting something in a beaker
AI-enabled drug discovery company Xaira launches with $1B
By Jessica Hagen | 03:21 pm | April 24, 2024
Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.